When did CLOVER HEALTH INVESTMENTS CO (CLOV) report earnings last quarter?
CLOVER HEALTH INVESTMENTS CO (CLOV) last reported earnings on 2/26/2026.
CLOVER HEALTH INVESTMENTS CO (CLOV) Earnings History & Surprises
NASDAQ:CLOV • US18914F1030
Current stock price
1.76 USD
+0.04 (+2.33%)
At close:
1.769 USD
+0.01 (+0.51%)
Pre-Market:
CLOV Earnings overview
Past quarterly earnings results for CLOVER HEALTH INVESTMENTS CO (CLOV), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.03
- Revenue Estimate
- 729.19M
Last Reported
Most Recent- Release Date
- Feb 26, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.10
- EPS Surprise
- 5.12%
- Revenue Surprise
- 2.37%
Beat Rate
Last 8 Quarters 69%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.10 | -0.11 | 5.12% | -150.00% | 487.707M | 476.4M | 2.37% | 44.74% |
| Q3 2025 | -0.05 | -0.03 | -63.40% | -150.00% | 496.65M | 480.51M | 3.36% | 50.05% |
| Q2 2025 | -0.02 | -0.03 | 28.70% | -300.00% | 477.62M | 477.66M | -0.01% | 34.07% |
| Q1 2025 | 0.00 | -0.06 | 100.00% | 100.00% | 462.331M | 489.07M | -5.47% | 33.27% |
| Q4 2024 | -0.04 | -0.07 | 39.67% | 71.43% | 336.963M | 390.2M | -13.64% | -33.96% |
| Q3 2024 | -0.02 | -0.04 | 50.98% | 77.78% | 330.986M | 353.2M | -6.29% | -31.34% |
| Q2 2024 | 0.01 | -0.05 | 120.14% | 116.67% | 356.26M | 345.54M | 3.10% | -30.64% |
| Q1 2024 | -0.04 | -0.07 | 45.78% | 73.33% | 346.922M | 327.65M | 5.88% | -34.27% |
| Q4 2023 | -0.14 | -0.14 | 1.49% | 20.00% | 510.251M | 489.86M | 4.16% | -43.23% |
| Q3 2023 | -0.09 | -0.11 | 16.50% | 43.75% | 482.066M | 504.49M | -4.44% | -43.74% |
| Q2 2023 | -0.06 | -0.15 | 60.89% | 72.73% | 513.628M | 500.64M | 2.59% | -39.34% |
| Q1 2023 | -0.15 | -0.18 | 16.35% | 21.05% | 527.775M | 508.71M | 3.75% | -39.64% |
| Q4 2022 | -0.18 | -0.26 | 32.77% | 38.38% | 898.8M | 801.09M | 12.20% | 108.06% |
| Q3 2022 | -0.16 | -0.24 | 34.37% | -100.00% | 856.8M | 815.45M | 5.07% | 100.56% |
| Q2 2022 | -0.22 | -0.21 | -4.60% | 71.79% | 846.7M | 830.91M | 1.90% | 105.26% |
| Q1 2022 | -0.19 | -0.28 | 31.87% | -46.15% | 874.4M | 803.16M | 8.87% | 336.55% |
| Q4 2021 | -0.28 | -0.27 | -5.80% | -42.00% | 432M | 416.3M | 3.77% | - |
| Q3 2021 | -0.08 | -0.23 | 65.64% | - | 427.2M | 421.36M | 1.39% | - |
| Q2 2021 | -0.78 | -0.14 | -465.07% | - | 412.5M | 209.49M | 96.91% | - |
| Q1 2021 | -0.13 | -0.11 | -15.16% | - | 200.3M | 196.42M | 1.98% | - |
| Q4 2020 | -0.20 | -0.86 | 76.66% | - | 170.3M | -100.00% | - | |
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
17.61%
Max EPS beat (4)
100.00%
Min EPS beat (4)
-63.40%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
0.06%
Max Revenue beat (4)
3.36%
Min Revenue beat (4)
-5.47%
Analysis
In the last 4 quarters, CLOV has beaten EPS estimates in 3 out of 4 releases
CLOV has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, CLOV has beaten the EPS estimates by 17.6% on average.
In the last 4 quarters, CLOV has beaten the revenue estimates by 0.1% on average.
Related analysis
CLOVER HEALTH INVESTMENTS CO / CLOV Earnings FAQ
Did CLOV stock beat earnings estimates in the most recent quarter?
CLOVER HEALTH INVESTMENTS CO (CLOV) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does CLOVER HEALTH INVESTMENTS CO (CLOV) beat earnings estimates?
In the last 4 quarters, CLOVER HEALTH INVESTMENTS CO (CLOV) has beaten EPS estimates in 3 out of 4 releases.